CRSP
Price
$41.84
Change
+$3.27 (+8.48%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
3.62B
66 days until earnings call
IOVA
Price
$2.05
Change
+$0.25 (+13.89%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
684.57M
62 days until earnings call
Interact to see
Advertisement

CRSP vs IOVA

Header iconCRSP vs IOVA Comparison
Open Charts CRSP vs IOVABanner chart's image
CRISPR Therapeutics AG
Price$41.84
Change+$3.27 (+8.48%)
Volume$47.6K
Capitalization3.62B
Iovance Biotherapeutics
Price$2.05
Change+$0.25 (+13.89%)
Volume$292.98K
Capitalization684.57M
CRSP vs IOVA Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. IOVA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and IOVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CRSP: $38.57 vs. IOVA: $1.79)
Brand notoriety: CRSP and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 120% vs. IOVA: 50%
Market capitalization -- CRSP: $3.62B vs. IOVA: $684.57M
CRSP [@Biotechnology] is valued at $3.62B. IOVA’s [@Biotechnology] market capitalization is $684.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileIOVA’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • IOVA’s FA Score: 1 green, 4 red.
According to our system of comparison, IOVA is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 7 TA indicator(s) are bullish while IOVA’s TA Score has 7 bullish TA indicator(s).

  • CRSP’s TA Score: 7 bullish, 1 bearish.
  • IOVA’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, both CRSP and IOVA are a good buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а +4.87% price change this week, while IOVA (@Biotechnology) price change was -1.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

IOVA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.62B) has a higher market cap than IOVA($685M). CRSP YTD gains are higher at: -2.007 vs. IOVA (-75.743). IOVA has higher annual earnings (EBITDA): -354.01M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. IOVA (360M). IOVA has less debt than CRSP: IOVA (53.7M) vs CRSP (219M). IOVA has higher revenues than CRSP: IOVA (213M) vs CRSP (35M).
CRSPIOVACRSP / IOVA
Capitalization3.62B685M528%
EBITDA-455.24M-354.01M129%
Gain YTD-2.007-75.7433%
P/E RatioN/AN/A-
Revenue35M213M16%
Total Cash1.86B360M515%
Total Debt219M53.7M408%
FUNDAMENTALS RATINGS
CRSP vs IOVA: Fundamental Ratings
CRSP
IOVA
OUTLOOK RATING
1..100
114
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9294
PRICE GROWTH RATING
1..100
6497
P/E GROWTH RATING
1..100
78100
SEASONALITY SCORE
1..100
37n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for CRSP (65). This means that IOVA’s stock grew somewhat faster than CRSP’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRSP (100). This means that IOVA’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (92) in the Biotechnology industry is in the same range as IOVA (94). This means that CRSP’s stock grew similarly to IOVA’s over the last 12 months.

CRSP's Price Growth Rating (64) in the Biotechnology industry is somewhat better than the same rating for IOVA (97). This means that CRSP’s stock grew somewhat faster than IOVA’s over the last 12 months.

CRSP's P/E Growth Rating (78) in the Biotechnology industry is in the same range as IOVA (100). This means that CRSP’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPIOVA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVLAX20.03N/A
N/A
Fidelity Advisor Value Leaders A
BMCIX28.00N/A
N/A
BlackRock High Equity Income Instl
MSFJX19.21N/A
N/A
MFS Total Return R4
NEMRX21.71N/A
N/A
Neuberger Berman Emerg Mkts Eq R3
RUNTX23.75N/A
N/A
Russell Inv US Small Cap Equity M

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with PLX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then PLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-1.91%
PLX - IOVA
50%
Loosely correlated
-5.00%
ADMA - IOVA
46%
Loosely correlated
-1.92%
VCYT - IOVA
43%
Loosely correlated
-1.17%
ROIV - IOVA
42%
Loosely correlated
-0.18%
CRSP - IOVA
42%
Loosely correlated
+1.37%
More